Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Industry”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

[Ecological industry chain designing of making paper industry: turning pollution industry into ecological industry].

This paper gave a definition of ecological industry chain of renewal resources, and according to this definition designed the ecological industry chain of paper making industry of China; presented a basic principle of designing and ecological industry chain of renewal resources and five necessary conditions to establish an ecological industry chain of renewal resources, i.e. imitating the ecological closed-circuit system, increasing stock of renewal resources, getting benefits from resource productivity, developing long-run social demand and engaging in systematic innovation. It was found that the ecological industry chain of paper making industry was a representative example of ecological industry chain of renewal resources. The ecological industry chain of paper making industry solved three difficult constrain problems and offered an effective way to change the paper making industry of China from pollution industry into ecological industry.

Conservation of Natural Resources↗

Occupational lung diseases in the industrializing and industrialized world due to modern industries and modern pollutants.

Although most new 'high tech' industrial processes are developed in industrialized countries, many of these technologies are eventually transferred to the industrializing countries. Many of these new technologies are associated with the use of respiratory toxins. However, there has been little study of acute or chronic health effects of work in these industries. The semiconductor industry illustrates many of these issues. The past decade has been increasing globalization of semiconductor manufacturing. Semiconductor manufacturing uses many chemicals with extremely high respiratory toxicity, including gases such as arsine and phosphine, strong acids and bases, dopants and photoactive chemicals. In semiconductor manufacturing, gases and chemicals are strictly controlled, but little is known about the occurrence of respiratory symptoms or disease in this industry. Potential acute respiratory effects of these exposures include mucous membrane irritation, tracheobronchitis, pulmonary edema and death. Chronic effects may include airway sensitization and possibly respiratory cancer. Movement of 'high tech' industries to less industrialized countries may not be accompanied by the same degree of attention to the control of workplace exposures. The shortage of adequately trained health and safety personnel, greater attention to safety than to health issues, and the unorganized and unskilled workforce in industrializing countries may exacerbate this situation. More research is needed on the health effects of exposures in rapidly changing industries such as semiconductor manufacturing, and the results of this research must be communicated and safe practices implemented worldwide.

Antimony↗

[Environmental impact on the formation of the public opinion among the urban population with developed oil refining industry, chemical petroleum industry and chemical industry].

The research proved oil-processing, petrochemical and chemical enterprises to be potent releasers of chemical hazards containing in industrial waste. The petrochemical and oil enterprises pollute environment and deteriorate sanitary conditions in populated area. The residents evaluate actual ecologic danger adequately. Sociologic analysis of how city dwellers assess quality of their environment and health is quate objective indicator of urban ecology and could be assigned to priority methods of ecologic and hygienic studies.

Adult↗

Industrial ecology: a new perspective on the future of the industrial system.

Industrial ecology? A surprising, intriguing expression that immediately draws our attention. The spontaneous reaction is that "industrial ecology" is a contradiction in terms, something of an oxymoron, like "obscure clarity" or "burning ice". Why this reflex? Probably because we are accustomed to considering the industrial system as isolated from the Biosphere, with factories and cities on one side and nature on the other, as well as the recurrent problem of trying to minimise th impact of the industrial system on what is "beyond" it: its surroundings, the "environment". As early as the 1950's, this end-of-pipe angle was the one adopted by ecologists, whose first serious studies focused on the consequences of the various forms of pollution on nature. In this perspective on the industrial system, human industrial activity as such remained outside the field of research. Industrial ecology explores the opposite assumption: The industrial system can be seen as a certain kind of ecosystem. After all, the industrial system, just as natural ecosystems, can be described as a particular distribution of materials, energy, and information flows. Furthermore, the entire industrial system relies on resources and services provided by the Biosphere, from which it cannot be dissociated. (It should be specified that "industrial", in the context of industrial ecology, refers to all human activities occurring within modern technological society. Thus, tourism, housing, medical services, transportation, agriculture, etc. are part of the industrial system.) Besides its rigorous scientific conceptual framework (scientific ecology), industrial ecology can also be seen as a practical approach to sustainability. It is an attempt to address the question, "How can the concept of sustainable development be made operational in an economically feasible way?" Industrial ecology represents precisely one of the paths that could provide concrete solutions. Governments have traditionally approached development and environmental issues in a fragmented and compartmentalised way. This is illustrated in the classical end-of-pipe strategy for the treatment of pollution, which has proven to be quite useful, but not adequate to make an efficient use of limited resources, in the context of a growing population with increasing economic aspirations. Thus, industrial ecology emerges at a time when it is becoming increasingly clear that the traditional pollution treatment approach (end-of-pipe) is not only insufficient to solve environmental problems, but also too costly in the long run.

Ecology↗

Industrial sustainability in China: practice and prospects for eco-industrial development.

China is a large densely populated country undergoing rapid industrialization and is becoming one of the world's biggest consumers of natural resources. This circumstance provides a sharp contrast with other countries. As China is so significant in the global economy, studies of its eco-industrial development are very important. In this study we examined the state of eco-industrial development in China and have drawn conclusions from this analysis about some of the future prospects for sustainable development. In the analysis, we investigated the application of industrial ecology concepts by reference to several case studies. We have therefore described the current environmental situation in China, and have provided an overview of eco-industrial development and its implementation. Constraints to industrial sustainability in China have also been examined. We consider that eco-industrial development in China is in its infancy, and that closed loops involving chains and industrial symbiotic webs are the technological key and core of successful initiatives in the application of industrial ecology. In the case studies, we found that each system has different characteristics and management concerns. Our major conclusion is that even though China's Agenda 21 highlights the principles and sets the directions for eco-industrial development, these have not yet become essential ingredients in the country's industrial policy and practice for implementing Agenda 21.

China↗

Tobacco industry manipulation of the hospitality industry to maintain smoking in public places.

OBJECTIVE: To describe how the tobacco industry used the "accommodation" message to mount an aggressive and effective worldwide campaign to recruit hospitality associations, such as restaurant associations, to serve as the tobacco industry's surrogate in fighting against smoke-free environments. METHODS: We analysed tobacco industry documents publicly available on the internet as a result of litigation in the USA. Documents were accessed between January and November 2001. RESULTS: The tobacco industry, led by Philip Morris, made financial contributions to existing hospitality associations or, when it did not find an association willing to work for tobacco interests, created its own "association" in order to prevent the growth of smoke-free environments. The industry also used hospitality associations as a vehicle for programmes promoting "accommodation" of smokers and non-smokers, which ignore the health risks of second hand smoke for employees and patrons of hospitality venues. CONCLUSION: Through the myth of lost profits, the tobacco industry has fooled the hospitality industry into embracing expensive ventilation equipment, while in reality 100% smoke-free laws have been shown to have no effect on business revenues, or even to improve them. The tobacco industry has effectively turned the hospitality industry into its de facto lobbying arm on clean indoor air. Public health advocates need to understand that, with rare exceptions, when they talk to organised restaurant associations they are effectively talking to the tobacco industry and must act accordingly.

Civil Rights↗

Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead.

The relationship between healthcare professionals and the pharmaceutical industry is under intense scrutiny. Accusations of corrupt practices have been levelled at the industry by both the professional and the lay press. The environment is changing, with rising expectations of transparency and ethical standards. In addition, society is becoming increasingly risk averse. There have been examples of poor practice by industry in the past, and industry is learning from these. Equally, there are many examples of excellent practice where industry has worked effectively and ethically with clinicians. The goal of industry is to bring new medicines to benefit patients and shareholders. Commercial success is dependent upon putting the patient at the centre of activity. It also allows re-investment into research and development. This allies industry and healthcare professionals with a common and key ethical arbitrator--the patient. Industry is changing as an acknowledgement of the need to adapt to the culture change demanded by society. Self regulation is increasingly active and transparent; guidelines, laws and internal/external regulators exist to examine industry. However, for the changes in regulations, behaviour and practices to be fully effective, there is a need for dialogue between industry and healthcare professionals. Commitment is needed from both sides to work together to manage the relationship.

Drug Industry↗

Tobacco industry efforts at discrediting scientific knowledge of environmental tobacco smoke: a review of internal industry documents.

STUDY OBJECTIVE: Using tobacco industry internal documents to investigate the use of tobacco industry consulting scientists to discredit scientific knowledge of environmental tobacco smoke (ETS). DESIGN: Basic and advanced searches were performed on the Philip Morris, Tobacco Institute, R J Reynolds, Brown and Williamson, Lorillard, and the Council for Tobacco Research document web sites, with a concentration on the years 1985-1995. Guildford depository files located on the Canadian Council on Tobacco Control website were also searched. The documents were found in searches undertaken between 1 March and 30 June 2000. MAIN RESULTS: The industry built up networks of scientists sympathetic to its position that ETS is an insignificant health risk. Industry lawyers had a large role in determining what science would be pursued. The industry funded independent organisations to produce research that appeared separate from the industry and would boost its credibility. Industry organised symposiums were used to publish non-peer reviewed research. Unfavourable research conducted or proposed by industry scientists was prevented from becoming public. CONCLUSIONS: Industry documents illustrate a deliberate strategy to use scientific consultants to discredit the science on ETS.

Air Pollution, Indoor↗

Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

BACKGROUND: Conflicting reports exist in the medical literature regarding the association between industry funding and published research findings. In this study, we examine the association between industry funding and the statistical significance of results in recently published medical and surgical trials. METHODS: We examined a consecutive series of 332 randomized trials published between January 1999 and June 2001 in 8 leading surgical journals and 5 medical journals. Each eligible study was independently reviewed for methodological quality using a 21-point index with 5 domains: randomization, outcomes, eligibility criteria, interventions and statistical issues. Our primary analysis included studies that explicitly identified the primary outcome and reported it as statistically significant. For studies that did not explicitly identify a primary outcome, we defined a "positive" study as one with at least 1 statistically significant outcome measure. We used multivariable regression analysis to determine whether there was an association between reported industry funding and trial results, while controlling for study quality and sample size. RESULTS: Among the 332 randomized trials, there were 158 drug trials, 87 surgical trials and 87 trials of other therapies. In 122 (37%) of the trials, authors declared industry funding. An unadjusted analysis of this sample of trials revealed that industry funding was associated with a statistically significant result in favour of the new industry product (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.3-3.5). The association remained significant after adjustment for study quality and sample size (adjusted OR 1.8, 95% CI 1.1-3.0). There was a nonsignificant difference between surgical trials (OR 8.0, 95% CI 1.1-53.2) and drug trials (OR 1.6, 95% CI 1.1-2.8), both of which were likely to have a pro-industry result (relative OR 5.0, 95% CI 0.7-37.5, p = 0.14). INTERPRETATION: Industry-funded trials are more likely to be associated with statistically significant pro-industry findings, both in medical trials and surgical interventions.

Conflict of Interest↗